A review on nanostructured silver as a basic ingredient in medicine: physicochemical parameters and characterization.
Gabriel M MisirliKishore SridharanShirley M P AbrantesPublished in: Beilstein journal of nanotechnology (2021)
Recent studies with silver nanoparticles (AgNPs) and the history of silver metal as a broad-spectrum bactericidal and virucidal agent, places silver as one of the future biocidal candidates in the field of nanomedicine to eliminate bacteria and viruses, especially multidrug resistant ones. In this review, we have described the various morphologies of AgNPs and correlated the enhanced bactericidal activity with their prominent {111} facets. In addition to prioritizing the characterization we have also discussed the importance of quantifying AgNPs and silver ion content (Ag+) and their different mechanisms at the chemical, biological, pharmacological, and toxicological levels. The mechanism of action of AgNPs against various bacteria and viruses including the SARS-CoV-2 was analyzed in order to understand its effectiveness as an antimicrobial agent with therapeutic efficacy and low toxicity. Further, there is the need to characterize AgNPs and quantify the content of free Ag+ for the implementation of new systematic studies of this promising agent in nanomedicine and in clinical practice.
Keyphrases
- silver nanoparticles
- sars cov
- multidrug resistant
- clinical practice
- randomized controlled trial
- quantum dots
- healthcare
- systematic review
- primary care
- highly efficient
- drug resistant
- respiratory syndrome coronavirus
- pseudomonas aeruginosa
- acinetobacter baumannii
- escherichia coli
- cystic fibrosis
- gold nanoparticles
- current status
- genetic diversity
- klebsiella pneumoniae
- coronavirus disease